stem
cell
line
may
contain
endogen
viru
contamin
exogen
virus
even
anim
origin
may
secret
viral
particl
express
viral
antigen
surfac
moreov
certain
biotechnolog
product
eg
bovin
fetal
serum
murin
feeder
cell
may
contain
prion
particl
viral
prion
contamin
cell
cultur
feeder
cell
common
risk
biotechnolog
product
deriv
cell
line
challeng
potenti
seriou
outcom
address
due
difficulti
involv
viru
prion
detect
potenti
caus
seriou
diseas
recipi
cell
product
stem
cell
bank
introduc
adequ
qualiti
assur
program
like
microbiolog
control
program
provid
research
valuabl
support
standard
safeti
procedur
protocol
use
viral
prion
test
valid
program
assur
qualiti
safeti
cell
new
treatment
cell
therapi
base
transplant
cell
human
origin
still
problem
difficulti
cultur
differenti
cell
possibl
chromosom
alter
potenti
tumorigen
particular
import
possibl
transmiss
infecti
diseas
recipi
cell
product
microbi
contamin
donor
biolog
product
introduc
manufactur
process
potenti
present
seriou
hazard
recipi
even
overt
pathogen
common
potenti
form
contamin
eg
bacteria
includ
mycoplasma
yeast
fungi
readili
assess
routin
basi
european
pharmacopeia
pharmacopeia
cobo
et
al
howev
viral
contamin
cell
cultur
feeder
cell
common
risk
biotechnolog
product
deriv
cell
line
challeng
potenti
seriou
outcom
address
due
difficulti
involv
viru
detect
potenti
caus
seriou
diseas
recipi
cell
product
cobo
et
al
ensur
provis
safe
reliabl
cell
tissu
applic
necessari
regul
procur
process
test
preserv
storag
distribut
cell
appli
human
bodi
direct
stem
cell
bank
must
assur
qualiti
safeti
cell
aim
particularli
import
avoid
transmiss
diseas
like
viral
prion
infect
difficult
diagnos
establish
introduc
adequ
qualiti
assur
program
like
microbiolog
control
program
respect
accredit
stem
cell
bank
provid
research
valuabl
support
standard
safeti
procedur
protocol
use
viral
prion
test
valid
program
assur
qualiti
safeti
cell
review
discuss
methodolog
use
stem
cell
bank
order
assur
qualiti
cell
biotechnolog
product
avoid
transmiss
infect
particular
involv
viru
prion
particl
line
cell
cultur
may
contain
endogen
viru
contamin
exogen
virus
may
secret
viral
particl
express
viral
antigen
surfac
moreov
certain
biotechnolog
product
eg
bovin
fetal
serum
may
contain
prionic
particl
primari
sourc
potenti
viral
prionic
contamin
come
infect
anim
tissu
use
prepar
biolog
reagent
media
biolog
product
donor
eg
bone
marrow
preembryo
contamin
laboratori
manipul
addit
infect
laboratori
worker
may
caus
contamin
stem
cell
line
cultur
manipul
requir
feeder
cell
anim
origin
eg
murin
cell
maintain
undifferenti
growth
human
embryon
stem
cell
hesc
cultur
provid
intim
contact
potenti
therapeut
cell
feeder
cell
ideal
set
transmit
infecti
microorgan
bioactiv
molecul
final
therapeut
product
evid
certain
mous
virus
like
hantaan
viru
lymphocyt
choriomening
viru
lcmv
detect
mous
coloni
kraft
meyer
virus
notabl
caus
seriou
infect
even
fatal
laboratori
worker
lloyd
jone
mahi
et
al
may
also
transmit
cell
line
reagent
nickla
et
al
event
use
feeder
cell
human
origin
draper
et
al
genbacev
et
al
numer
virus
infecti
agent
suscept
transmit
recipi
human
cell
potenti
transmit
infecti
diseas
screen
appli
test
human
feeder
cell
clinic
use
present
regul
requir
screen
cell
tissu
product
donor
spectrum
virus
caus
seriou
human
infecti
diseas
uk
msbt
aatb
virolog
screen
firstli
carri
hepat
b
hepat
c
moreov
recent
product
transfus
contain
cellular
materi
test
cell
associ
organ
hcmv
htlviii
consensu
document
although
test
hepat
hepat
e
also
recommend
product
potenti
viral
agent
could
contamin
cell
healthi
individu
includ
human
herpesvirus
epstein
barr
viru
herp
simplex
viru
parvoviru
ttv
viru
human
polyomavirus
jc
bk
viru
virus
remain
latent
detect
human
earli
childhood
risk
transmiss
microorgan
consid
extrem
low
test
current
requir
transplant
howev
oncogen
risk
viral
contamin
must
also
consid
agent
involv
human
cancer
takeuchi
et
al
garbuglia
et
al
microbi
agent
mark
variat
geograph
distribut
produc
infecti
epidem
differ
area
like
lymphocyt
choriomening
viru
usa
wnv
updat
recent
outbreak
sever
acut
respiratori
syndrom
sar
viru
human
south
east
asia
furthermor
two
new
retrovirus
recent
identifi
among
african
bushmeat
hunter
wolf
et
al
recent
case
transplant
transmit
diseas
due
rabi
viru
usa
germani
srinivasan
et
al
report
clearli
show
potenti
emerg
new
seriou
pathogen
reemerg
known
pathogen
obvious
new
entiti
aris
consid
contamin
risk
factor
specif
test
may
requir
may
develop
surveil
initi
case
sar
detect
method
develop
caus
coronaviru
agent
juang
et
al
use
bovin
fetal
serum
stem
cell
cultur
requir
urgent
need
risk
assess
transmiss
spongiform
encephalopathi
tse
mean
sensit
specif
test
product
deriv
rumin
us
food
drug
administr
direct
cell
cultur
repres
good
medium
promot
allow
persist
replic
prp
sc
maintain
infect
even
heterolog
cell
cultur
model
solassol
et
al
human
be
expos
secondari
infect
tse
use
medic
procedur
administ
biolog
product
deriv
human
includ
blood
llewelyn
et
al
peden
et
al
thu
prevent
measur
taken
account
respect
blood
product
cell
tissu
graft
order
avoid
prion
transmiss
recipi
vitro
assay
viral
detect
viral
cultur
virus
oblig
intracellular
parasit
requir
live
cell
order
replic
sinc
virus
requir
cellular
machineri
replic
live
system
must
use
viral
cultur
amplif
method
increas
amount
pathogen
facilit
detect
character
method
uniqu
among
detect
method
provid
isol
viabl
viru
character
store
futur
studi
anoth
import
featur
cultur
method
allow
detect
mani
differ
virus
includ
suspect
time
cultur
establish
even
virus
previous
known
discov
cell
lysat
specimen
eg
biolog
product
specimen
donor
introduc
cell
cultur
capabl
detect
wide
rang
virus
instruct
obtain
transport
specimen
previous
report
storch
usual
minimum
three
cell
line
includ
human
diploid
cell
line
monkey
kidney
cell
line
vero
cell
type
speci
tissu
type
use
product
schiff
recommend
addit
cell
may
requir
depend
cell
sourc
passag
histori
raw
materi
use
inocul
cultur
incub
c
either
day
inspect
period
eg
daili
observ
cytopath
effect
sever
virus
includ
recent
report
method
analysi
hiv
viru
cytopath
use
jurkat
cell
cultur
speir
et
al
certain
circumst
observ
period
greater
day
identif
mani
virus
eg
human
cytomegaloviru
viru
detect
test
inocul
cell
cultur
hemadsorpt
andor
hemagglutin
ayala
et
al
necessari
virus
minim
visibl
cytopath
effect
howev
viral
cultur
also
signific
disadvantag
diagnost
method
includ
need
special
facil
expertis
expens
rel
prolong
time
detect
european
medicin
evalu
agenc
emea
us
food
drug
administr
us
food
drug
administr
recommend
use
studi
anim
screen
method
wide
rang
virus
studi
consist
inocul
mice
pig
embryon
chicken
egg
cell
lysat
biolog
product
caus
clinic
chang
anim
speciesspecif
virus
potenti
present
rodent
cell
stem
cell
murin
feeder
test
antibodi
product
test
like
mous
hamster
rat
test
map
murin
virus
hap
virus
rap
virus
test
carri
inocul
virusfre
anim
specif
time
examin
serum
antibodi
level
howev
test
take
number
week
therefor
prove
difficult
implement
schedul
releas
test
time
critic
product
viral
infect
occasion
diagnos
use
electron
microscopi
direct
visual
viral
particl
specimen
introduct
neg
stain
late
brenner
horn
wider
avail
electron
microscop
electron
microscopi
becam
essenti
character
mani
new
isol
detect
cell
cultur
clinic
sampl
plummer
et
al
biel
gelderblom
pattern
recognit
eg
inform
size
particl
morpholog
lead
rapid
identif
infecti
agent
open
procedur
electron
microscop
test
allow
unbias
rapid
detect
virus
agent
suffici
high
particl
concentr
exist
due
capabl
electron
microscop
test
must
frontlin
method
appli
cell
cultur
cultiv
agent
specimen
readi
examin
experienc
virologist
technologist
identifi
electron
microscopi
viral
pathogen
morpholog
within
minut
arriv
electron
microscopi
laboratori
advantag
electron
microscopi
includ
lack
requir
viral
viabil
fact
mani
differ
kind
viral
particl
potenti
seen
allow
differenti
diagnosi
mani
agent
contain
specimen
disadvantag
includ
cost
complex
maintain
electron
microscop
although
fact
correct
work
institut
central
servic
need
skill
oper
rel
lack
sensit
relat
fact
rel
high
concentr
viral
particl
per
millilit
requir
visual
miller
respect
question
paper
relev
point
discuss
biel
madeley
two
type
electron
microscopi
method
direct
immunoelectron
microscopi
direct
method
neg
stain
normal
use
requir
littl
special
equip
contrast
thin
section
techniqu
specimen
may
use
directli
viru
particl
may
concentr
neg
stain
sever
method
avail
concentr
includ
differenti
centrifug
ammonium
persulf
precipit
agar
diffus
method
immunoelectron
microscopi
mean
increas
sensit
specif
electron
microscopi
particularli
use
number
viru
particl
present
small
detail
effici
sampl
collect
prepar
particl
enrich
publish
previous
gelderblom
hazelton
hazelton
gelderblom
detect
viral
antigen
directli
clinic
specimen
cell
cultur
becom
essenti
compon
methodolog
repertoir
diagnost
virolog
method
provid
diagnost
inform
within
hour
receipt
specimen
lack
requir
viru
viabil
anoth
import
advantag
viral
cultur
especi
specimen
transport
time
prolong
otherwis
suboptim
antigen
detect
method
appli
follow
condit
met
viral
antigen
express
present
access
specimen
ii
appropri
antibodi
avail
iii
antigen
variabl
preclud
recognit
immunolog
reagent
differ
strain
target
viru
iv
antigen
detect
suffici
stabl
degrad
transport
process
specimen
method
use
viral
antigen
detect
includ
fluoresc
antibodi
stain
fa
immunoperoxidas
stain
enzym
immunoassay
eia
fa
wide
use
detect
cell
associ
viral
antigen
direct
format
fluoresc
label
usual
fluorescein
isothiocyan
fitc
conjug
directli
antibodi
recogn
viral
antigen
indirect
format
antivir
antibodi
unlabel
detect
second
antibodi
recogn
immunoglobulin
anim
speci
origin
antivir
antibodi
second
antibodi
carri
fluoresc
label
stain
specimen
view
epiilumin
use
ultraviolet
light
wavelength
need
excit
fluoresc
label
direct
method
simpler
use
requir
conjug
antivir
antibodi
fluoresc
label
indirect
method
slightli
sensit
versatil
antiimunoglobulin
antibodi
conjug
fluoresc
label
fa
method
wide
use
detect
hsv
hcmv
virus
similar
principl
fa
except
horseradish
peroxidas
use
place
fluoresc
label
advantag
method
stain
view
light
microscopi
thu
obviat
need
fluoresc
microscop
disadvantag
ip
method
cumbersom
fa
endogen
peroxidas
specimen
produc
background
stain
eia
wide
use
method
appli
detect
antigen
regardless
whether
cell
associ
sinc
intact
cell
specimen
requir
specimen
integr
less
import
fa
advantag
eia
includ
applic
divers
specimen
potenti
autom
virus
antigen
eia
wide
use
hsv
hbv
hiv
measur
antivir
antibodi
one
first
method
use
specif
diagnosi
viral
infect
role
serolog
viral
diagnosi
cell
cultur
may
determin
immun
statu
donor
biolog
materi
import
use
sensit
assay
eia
immunofluoresc
western
blot
assay
etc
howev
research
shown
detect
antibodi
exclus
run
risk
sampl
test
taken
antibodyneg
window
period
infect
individu
expos
viral
infect
inde
virem
hitzler
runkel
find
led
introduct
nucleic
acid
amplif
techniqu
polymeras
chain
reaction
pcr
presenc
viru
observ
mean
amplif
sequenc
viral
genom
addit
nucleic
acid
test
method
screen
tissu
donor
test
deriv
cell
line
reduc
risk
infect
among
recipi
stem
cell
line
zou
et
al
diagnost
virolog
revolution
applic
nucleic
acid
detect
techniqu
tang
et
al
nucleic
acidbas
diagnost
test
detect
specif
viru
diagnost
reagent
direct
method
detect
specif
nucleic
acid
sequenc
appli
detect
virtual
viru
depend
target
sequenc
assay
specif
singl
viru
speci
group
relat
virus
nucleic
acid
amplif
assay
particularli
attract
virus
difficult
imposs
cultur
virus
grow
slowli
cultur
virus
antigen
detect
appli
antigen
divers
level
viral
antigen
low
permit
success
detect
pcr
prototyp
target
amplif
assay
invent
kari
mulli
mulli
faloona
mulli
pcr
base
abil
dna
polymeras
copi
strand
dna
elong
complementari
strand
initi
pair
close
space
chemic
synthes
oligonucleotid
primer
includ
repeat
cycl
amplifi
select
nucleic
acid
sequenc
mulli
faloona
mulli
pcr
amplif
pcr
product
amplicon
detect
gel
electrophoresi
one
sever
probehybrid
techniqu
southern
blot
numer
modif
standard
pcr
procedur
develop
sinc
incept
erlich
et
al
wagar
modif
effect
expand
diagnost
capabl
pcr
increas
util
microbiolog
laboratori
rtpcr
develop
amplifi
rna
target
process
rna
target
first
convert
complementari
dna
cdna
revers
transcriptas
rt
amplifi
pcr
rtpcr
play
import
role
diagnos
rna
contain
viru
infect
young
et
al
sever
new
pcr
assay
develop
synthesi
pcr
product
detect
realtim
realtim
quantit
pcr
gibson
et
al
heid
et
al
realtim
quantit
pcr
homogen
method
includ
amplif
analysi
need
slab
gel
radioact
sampl
manipul
reaction
product
detect
fluoresc
detect
system
consist
lightemit
diod
deliv
excit
light
reaction
tube
optic
unit
three
detect
channel
record
emit
light
fluoresc
dna
dye
probe
monitor
cycl
pcr
simplest
system
detect
realtim
pcr
product
use
dnabind
dye
sybr
green
fluoresc
bind
doublestrand
dna
method
sever
import
advantag
convent
pcr
sinc
accumul
pcr
product
monitor
reaction
tube
separ
detect
method
gel
electrophoresi
requir
thu
shorten
effect
assay
markedli
furthermor
possibl
contamin
amplicon
decreas
system
close
handl
reaction
content
complet
pcr
use
multipl
fluoresc
dye
differ
emiss
wavelength
make
possibl
perform
multiplex
reaction
simultan
amplif
one
product
moreov
molecular
method
describ
introduc
viral
diagnosi
like
nucleic
acid
probe
denniston
et
al
branch
dna
signal
amplif
urdea
et
al
nest
pcr
erlich
et
al
multiplex
pcr
dineva
et
al
etc
realtim
multiplex
pcr
analyz
multipl
virus
simultan
within
singl
reaction
main
advantag
multiplex
singletarget
analysi
abil
provid
intern
control
lower
reagent
cost
preserv
preciou
sampl
multiplex
particularli
import
need
analyz
sever
virus
sampl
sever
assay
use
realtim
multiplex
rtpcr
technolog
diagnosi
hepat
b
viru
hepat
c
viru
viru
candotti
et
al
author
describ
sever
assay
use
procedur
retrovirus
vet
et
al
herpesvirus
oneil
et
al
advantag
molecular
method
especi
pcr
techniqu
extrem
high
sensit
may
detect
one
viral
genom
per
sampl
volum
easi
set
fast
turnaround
time
howev
main
inconveni
viru
group
viru
one
pcr
necessari
amount
virus
carri
larg
techniqu
unviabl
laboratori
retrovirus
one
main
contamin
cell
cultur
virus
revers
transcriptas
assay
electron
microscopi
techniqu
infect
assay
must
includ
varieti
infect
assay
avail
rodent
cell
line
stem
cell
line
murin
feeder
two
retroviru
infect
assay
ecotrop
xenotrop
virus
xc
plaqu
assay
use
indic
cell
xc
form
syncytia
plaqu
detect
ecotrop
virus
lenz
haseltin
mink
l
assay
detect
xenotrop
virus
li
et
al
howev
test
suitabl
detect
quantifi
level
ecotrop
recombin
viru
thu
serolog
focu
assay
base
specif
antimurin
leukemia
viru
mulv
viral
envelop
antibodi
requir
detect
ecotrop
recombin
viru
deo
et
al
moreov
low
level
murin
retrovirus
amplif
may
achiev
use
cocultiv
cell
suscept
cell
line
mu
dunni
cell
revers
transcriptas
assay
enzymat
techniqu
detect
presenc
extracellular
retroviru
particl
assay
base
abil
revers
transcriptas
associ
retrovirus
synthes
radiolabel
nucleotid
complementari
dna
cdna
copi
synthet
templat
due
fact
varieti
enzym
capabl
incorpor
label
deoxynucleotid
acidinsolubl
materi
assay
suscept
fals
posit
use
test
elimin
fals
posit
compar
result
dna
templat
ribonucl
acid
rna
templat
cellular
dna
polymeras
viral
revers
transcriptas
differ
templat
prefer
furthermor
pcrbase
revers
transcriptas
assay
sensit
standard
enzymat
revers
transcriptas
assay
electron
microscopi
see
use
visual
ultrastructur
morpholog
cell
substrat
presenc
viru
viruslik
particl
develop
microarray
fuel
applic
robot
technolog
routin
molecular
biolog
rather
fundament
breakthrough
southern
northern
blot
techniqu
detect
specif
dna
mrna
speci
provid
technolog
basi
microarray
hybrid
construct
array
involv
spot
specif
dna
sequenc
glass
slide
small
silicon
chip
photolithograph
combinatori
chemistri
method
similar
use
make
electron
chip
membranebas
array
may
format
line
probe
blot
result
hybrid
bound
probe
label
sequenc
sampl
appli
test
reveal
scan
imag
array
surfac
confoc
microscopi
use
scan
chip
detect
fluoresc
signal
reveal
hybrid
precis
locat
chip
use
probe
repres
possibl
nucleotid
sequenc
variat
within
target
sequenc
allow
rapid
determin
nucleotid
sequenc
peas
et
al
high
densiti
array
may
thousand
individu
probe
per
cm
refer
microarray
microarray
silicon
surfac
therefor
known
dna
chip
mani
dna
sequenc
present
slide
possibl
microarray
analysi
test
multipl
pathogen
includ
virus
simultan
first
applic
diagnost
virolog
rapid
sequenc
detect
hiv
mutat
associ
resist
antiretrovir
drug
kozal
et
al
role
virolog
diagnosi
recogn
caus
agent
ill
molecular
type
eg
patient
manag
epidemiolog
reason
purpos
relat
vaccin
use
research
investig
interact
viru
host
cell
clewley
rna
express
human
cmv
cell
cultur
presenc
absenc
cycloheximid
ganciclovir
analyz
array
oligonucleotid
repres
human
cmv
orf
chamber
et
al
group
develop
microarray
detect
simultan
discrimin
sever
virus
like
orthopoxviru
speci
laassri
et
al
respiratori
virus
coira
et
al
herpesvirus
enterovirus
flavivirus
korimbocu
et
al
hepat
c
viru
xu
et
al
also
wilson
et
al
develop
multipathogen
identif
microarray
system
identif
pathogen
prokaryot
eukaryot
virus
simplic
microarray
protocol
togeth
use
larg
number
speciesspecif
oligoprob
abil
analyz
multipl
sampl
short
time
offer
clear
advantag
howev
techniqu
need
care
valid
sensit
specif
appli
safeti
test
human
tissu
product
stem
cell
line
therapi
tabl
show
comparison
diagnost
method
virus
proteom
also
hold
key
posit
new
function
genom
biolog
term
larg
scale
analysi
protein
proteom
encompass
differ
method
identifi
protein
present
cell
tissu
protein
array
prepar
antigen
antibodi
bound
solid
phase
analog
oligonucleotid
amplicon
probe
use
captur
specif
antibodi
antigen
emili
cagney
walter
et
al
essenti
immunoassay
microarray
format
schweitzer
kingsmor
protein
array
describ
torch
screen
toxoplasma
gondii
rubella
viru
cmv
antigen
print
glass
slide
slide
first
incub
serum
sampl
subsequ
fluoresc
label
secondari
antibodi
human
igg
igm
bound
print
antigen
detect
confoc
scan
microscopi
good
concord
obtain
microarray
result
elisa
mezzasoma
et
al
microarray
oligosaccharid
nitrocellulos
develop
captur
carbohydraterecogn
protein
might
possibl
develop
viral
diagnosi
fukui
et
al
biosensor
defin
small
devic
use
biolog
reaction
detect
target
analyt
wang
two
way
bioaffin
array
involv
target
analyt
bind
ligand
immobil
solid
phase
eg
oligonucleotid
instead
necess
detect
hybrid
probe
target
colorimetr
radioact
mean
hybrid
detect
electron
mean
biocatalyt
array
involv
immobil
enzym
use
recogn
substrat
enzym
case
target
array
signal
gener
enzym
catalyz
specif
reaction
presenc
target
analyt
appli
array
reaction
may
recogn
either
colorimetr
alli
via
electron
transduc
surfac
array
technolog
advanc
proteinantibodi
array
like
impact
initi
infecti
diseas
research
profil
sera
bodi
fluid
discov
diagnost
marker
particular
infect
proteom
techniqu
also
offer
potenti
discov
marker
diagnost
test
viral
infect
vitro
eg
stem
cell
cultur
interest
potenti
infect
cell
cultur
may
discoveri
biolog
marker
prion
infect
mainli
compar
control
versu
infect
cultur
type
experi
first
perform
genet
level
develop
sophist
proteom
approach
sever
group
look
differenti
express
protein
could
use
diagnost
marker
least
could
give
clue
physiopatholog
event
lead
prion
propag
develop
cell
line
highli
suscept
prion
infect
bosqu
prusin
nishida
et
al
anoth
potenti
cell
cultur
consist
detect
infect
variou
biolog
sampl
main
sourc
transmiss
prion
protein
cultur
cell
bovin
fetal
serum
feeder
cell
murin
anim
biolog
product
donor
tse
establish
stem
cell
line
stem
cell
bank
urgent
need
test
agent
tse
creutzfeldtjakob
diseas
us
food
drug
administr
moment
sever
type
test
use
question
cell
prion
protein
prp
c
essenti
pathogenesi
transmiss
prion
diseas
prusin
cours
prion
diseas
larg
proteas
resist
aggreg
form
prp
design
prp
sc
accumul
mainli
brain
may
main
constitu
prion
mckinley
et
al
detect
protein
carri
mean
antibodi
monoclon
subtyp
antiprp
enari
et
al
parizek
et
al
antibodi
recogn
sequenc
dyedryyr
prion
protein
human
prp
amino
acid
sequenc
conserv
known
mammalian
prp
sequenc
human
cattl
sheep
rabbit
mink
varieti
primat
use
western
blot
elisa
prionic
monoclon
antibodi
prion
protein
recogn
sequenc
lihfg
bovin
prion
protein
polyclon
antibodi
also
recogn
bovin
prp
recent
sanquin
reagent
sanquin
develop
new
monoclon
antiprion
antibodi
use
research
applic
clone
contrast
mani
antibodi
use
detect
prion
protein
broad
speci
reactiv
detect
prion
protein
demonstr
western
blot
human
cattl
sheep
deer
mice
hamster
current
avail
tse
test
base
fact
prp
c
normal
prion
protein
digest
proteinas
k
wherea
prp
sc
tse
specif
prion
rel
resist
degrad
proteas
special
featur
epitop
almost
hidden
nondigest
bovin
prp
sc
proteinas
k
digest
epitop
becom
avail
result
signific
increas
detect
digest
proteas
k
bind
prp
sc
high
affin
wherea
low
affin
nondigest
prp
sc
antibodi
test
broad
varieti
method
western
blot
ria
elisa
eliblot
fac
immunohistochemistri
cyclic
amplif
protein
misfold
saborio
et
al
develop
procedur
conceptu
similar
polymeras
chain
reaction
cycl
involv
cyclic
amplif
protein
misfold
prp
sc
method
could
allow
rapid
convers
excess
prp
c
proteas
resist
prp
sc
like
form
method
aggreg
form
prp
sc
incub
prp
c
disrupt
sonic
gener
multipl
smaller
unit
continu
format
new
prp
sc
cycl
amplif
proteas
resist
prp
present
sampl
correspond
newli
convert
protein
method
could
appli
diagnos
presenc
undetect
prion
infecti
agent
tissu
biolog
fluid
respect
recent
castilla
et
al
first
detect
resistantprotein
prp
sc
biochem
hamster
blood
mean
cyclic
amplif
protein
misfold
procedur
enabl
detect
prion
blood
sensit
specif
high
level
sensit
specif
indic
assay
offer
promis
design
sensit
biochem
test
blood
diagnosi
transmiss
spongiform
encephalopathi
implement
similar
blooddetect
procedur
human
culturedetect
method
stem
cell
line
undoubtedli
contribut
minim
risk
infect
agent
caus
transmiss
spongiform
encephalopathi
diagnosi
infect
produc
tse
carri
mean
detect
prionic
protein
prp
sc
differ
method
see
although
specif
diagnost
method
nearli
ironsid
lee
et
al
wadsworth
et
al
sensit
still
inadequ
assur
valu
neg
result
altern
method
would
consist
use
transgen
mice
would
vaccin
tissu
fluid
unknown
infect
cell
line
use
bovin
serum
obtain
stem
cell
bank
aris
necess
guarante
exist
appropri
sourc
cell
line
standard
way
use
research
human
therapi
clinic
trial
moreov
establish
assur
safeti
biolog
product
use
cell
therapi
major
risk
associ
use
biolog
product
regen
medicin
relat
cell
contamin
includ
seriou
human
pathogen
also
human
anim
virus
prion
capabl
multipli
produc
transmiss
infecti
diseas
select
test
stem
cell
line
biotechnolog
product
eg
bovin
serum
tripsin
cultur
media
one
part
strategi
establish
viral
safeti
program
cobo
et
al
technolog
avoid
anim
product
cultur
manufactur
develop
safeti
human
andor
anim
product
use
cell
cultur
respect
viral
prion
contamin
could
obtain
applic
exhaust
program
viral
screen
mean
combin
techniqu
abovement
tabl
presenc
virus
includ
nonpathogen
type
prion
human
therapeut
product
would
like
render
unaccept
clinic
use
moment
cell
bank
must
panel
test
detect
seriou
pathogen
like
endogen
virus
exogen
virus
prion
panel
test
necessarili
includ
revers
transcriptas
detect
gener
test
retrovirus
electron
microscopi
detect
differ
kind
viral
particl
character
mani
unknown
isol
present
cell
cultur
molecular
techniqu
like
pcr
convent
realtim
rtpcr
test
includ
virus
know
pose
risk
product
prion
detect
bank
must
procedur
base
western
blot
elisa
technolog
detect
antibodi
eg
present
cell
cultur
test
may
also
need
appli
cultur
reagent
anim
origin
test
perform
manufactur
care
evalu
accept
reagent
use
respect
use
feeder
cell
anim
origin
eg
murin
embryon
stem
cell
cultur
need
evalu
sever
virus
capabl
infect
human
primat
potenti
caus
seriou
infect
laboratori
worker
virus
antibodi
product
test
eg
map
rap
hap
conveni
procedur
addit
evalu
mean
electron
microscopi
sever
test
could
includ
screen
biolog
product
wide
rang
virus
vitro
cell
cultur
assay
studi
anim
emea
long
stand
techniqu
reli
abil
mani
virus
caus
cytopath
chang
cell
cultur
clinic
chang
anim
howev
difficulti
implement
laboratori
due
need
special
facil
expertis
rel
prolong
time
detect
eg
prove
difficult
implement
test
time
critic
product
high
cost
immedi
futur
technolog
base
use
hybrid
chip
use
microarray
immobil
oligonucleotid
antigensantibodi
virus
method
cyclic
amplif
protein
misfold
prp
sc
prion
provid
rapid
use
methodolog
identif
contamin
opinion
need
design
implement
methodolog
stem
cell
cultur
new
research
need
final
possibl
assert
absolut
absenc
viral
contamin
imposs
cover
potenti
viral
contamin
absenc
adequ
level
sensit
specif
diagnost
techniqu
sever
case
stem
cell
bank
could
potenti
permit
transmiss
viral
contamin
mani
patient
receiv
futur
stem
cell
therapi
balanc
risk
benefit
may
differ
tabl
viru
test
recommend
character
cell
line
modifi
dellepian
et
al
emea
test
master
bank
work
bank
cell
limit
electron
microscopi
revers
transcriptas
vitro
cell
inocul
vivo
anim
inocul
antibodi
product
test
b
infect
c
viru
specif
test
necessari
posit
retroviru
infect
test
b
eg
map
rap
hapusu
applic
rodent
cell
line
c
retrovirus
endogen
virus
test
cell
line
deriv
human
nonhuman
primat
cell
line
appropri
